Actively Recruiting

Phase Not Applicable
Age: 40Years - 80Years
All Genders
NCT07361198

Percutaneous Transcatheter Genicular Embolization in Osteoarthritis

Led by Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. · Updated on 2026-02-04

20

Participants Needed

1

Research Sites

199 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This clinical study investigates a minimally invasive treatment called percutaneous transcatheter embolization of knee arteries for patients with chronic knee pain caused by advanced knee osteoarthritis or persistent pain after total knee replacement. Osteoarthritis of the knee is a common degenerative condition that can lead to long-term pain, reduced mobility, and decreased quality of life, and some patients do not achieve sufficient relief with standard treatments. The study is based on the hypothesis that targeted embolization of small arteries supplying the inflamed tissues of the knee can safely reduce abnormal blood flow associated with inflammation, leading to pain relief and improved knee function. During the procedure, a thin catheter is guided through the blood vessels to the affected area of the knee, where a temporary embolic agent is administered to reduce pathological blood supply. The aim of the study is to evaluate the safety and effectiveness of this procedure by assessing changes in pain intensity, knee function, and quality of life over a follow-up period of up to 24 months. The results of this study may help determine whether this minimally invasive approach can offer a new treatment option for patients who have limited alternatives for managing chronic knee pain

CONDITIONS

Official Title

Percutaneous Transcatheter Genicular Embolization in Osteoarthritis

Who Can Participate

Age: 40Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 40 to 80 years
  • Chronic knee pain symptoms
  • Radiographically confirmed knee osteoarthritis grade II-IV or persistent pain after total knee replacement
  • Insufficient pain relief from standard conservative treatments
  • Ability to understand and consent to study procedures
  • Willingness and ability to follow study schedule and procedures
Not Eligible

You will not qualify if you...

  • Active local or systemic infection
  • Known coagulation disorders or anticoagulation that cannot be safely stopped
  • Significant peripheral arterial disease in lower limbs
  • Allergy or contraindication to iodinated contrast agents
  • Severe kidney impairment
  • History of fibromyalgia or other chronic pain syndromes
  • Pregnancy or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Masarykova nemocnice v Ústí nad Labem

Ústí nad Labem, Czechia, 40011

Actively Recruiting

Loading map...

Research Team

P

Patrik Matras, MUDr.

CONTACT

P

Pavol Viglas

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here